Relay Therapeutics, Inc. (RLAY)
13.03
-1.92
(-12.84%)
USD |
NASDAQ |
Apr 28, 16:00
13.15
+0.12
(+0.92%)
After-Hours: 07:29
Relay Therapeutics Shareholders Equity (Quarterly) : 567.06M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tyra Biosciences, Inc. | 259.18M |
| Spyre Therapeutics, Inc. | 715.24M |
| Revolution Medicines, Inc. | 1.631B |
| Celcuity, Inc. | 100.56M |
| Tango Therapeutics, Inc. | 346.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 621.33M |
| Total Liabilities (Quarterly) | 54.27M |
| Debt to Equity Ratio | 0.0572 |
| Current Ratio | 22.61 |
| Net Debt Paydown Yield | 0.24% |